Biomarker and in vitro chemoresistance profiles of undifferentiated ovarian cancers

被引：0
|
作者：
Chan, J. K.
Kapp, D. S.
Mechetner, E.
Yu, I.
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Stanford Univ, Stanford, CA 94305 USA
[3] Oncotech, Tustin, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2532
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Biomarker and in vitro chemoresistance profiles of undifferentiated ovarian cancers
    Chan, J. K.
    Kapp, D. S.
    Mechetner, E.
    Yu, I. R.
    GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 377 - 378
  • [2] In vitro chemoresistance and biomarker profiles are unique for histologic subtypes of epithelial ovarian cancer
    Cloven, NG
    Kyshtoobayeva, A
    Burger, RA
    Yu, IR
    Fruehauf, JP
    GYNECOLOGIC ONCOLOGY, 2004, 92 (01) : 160 - 166
  • [3] CLINICOPATHOLOGICAL IMPACT OF INTRINSIC CHEMORESISTANCE/CHEMOSENSITIVITY AND BIOMARKER PROFILES IN OVARIAN CANCER PATIENTS
    Sedlakova, I.
    Laco, J.
    Brigulova, K.
    Cervinka, M.
    Tosner, J.
    Student, V.
    Spacek, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1660 - 1660
  • [4] Chemoresistance and targeted therapies in ovarian and endometrial cancers
    Brasseur, Kevin
    Gevry, Nicolas
    Asselin, Eric
    ONCOTARGET, 2017, 8 (03) : 4008 - 4042
  • [5] MicroRNA expression profiles in ovarian cancers
    Kim, Yong Wook
    Bae, Su Mi
    Kim, Ji Yun
    Seo, Kyung In
    Cho, Young Lae
    Ahn, Woong Shick
    CANCER RESEARCH, 2009, 69
  • [6] Chemoresistance is mediated by ovarian cancer leader cells in vitro
    Karimnia, Nazanin
    Wilson, Amy L.
    Green, Emma
    Matthews, Amelia
    Jobling, Thomas W.
    Plebanski, Magdalena
    Bilandzic, Maree
    Stephens, Andrew N.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [7] Chemoresistance is mediated by ovarian cancer leader cells in vitro
    Nazanin Karimnia
    Amy L. Wilson
    Emma Green
    Amelia Matthews
    Thomas W. Jobling
    Magdalena Plebanski
    Maree Bilandzic
    Andrew N. Stephens
    Journal of Experimental & Clinical Cancer Research, 40
  • [8] Inhibition of PFKFB3/glycolysis overcomes chemoresistance in ovarian cancers
    Mondal, Susmita
    Roy, Debarshi
    Kalogera, Eleftheria
    Khurana, Ashwani
    Tapolsky, Gilles H.
    Telang, Sucheta
    Chesney, Jason
    Shridhar, Viji
    CANCER RESEARCH, 2015, 75
  • [9] MSLN Correlates With Immune Infiltration and Chemoresistance as a Prognostic Biomarker in Ovarian Cancer
    Li, Yike
    Tian, Wanjia
    Zhang, Hong
    Zhang, Zhijian
    Zhao, Qinghe
    Chang, Lei
    Lei, Ningjing
    Zhang, Weiwei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Tumor heterogeneity in ovarian cancer as demonstrated by in vitro chemoresistance assays
    McAlpine, J. N.
    Eisenkop, S. M.
    Spirtos, N. M.
    GYNECOLOGIC ONCOLOGY, 2008, 110 (03) : 360 - 364
12345